Company / Operating Cash Flow
Nuvalent, Inc. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$275.2M
FY2025
5-year range
-$275.2M / -$40.0M
FY2021-FY2025
Trend
-48.7%
vs FY2024
Sector context
#187 of 216
Health Care
What the data says
Nuvalent, Inc.'s operating cash flow of -$275M is lower than 87% of companies in the Health Care sector (FY2025). Operating Cash Flow has declined for 5 consecutive years, from -$15M in FY2020 to -$275M in FY2025.
Based on SEC 10-K filings.
-$275M in FY2025.
Declined from -$100M to -$275M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 216This company -$275.2M Sector average $658.7M
▼
-141.8% below sector average
Key checks
Key Insights
- Nuvalent, Inc.'s operating cash flow has declined for 5 consecutive years.
- In FY2025, operating cash flow decreased 48.7% year-over-year.
- Ranks #187 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$275.2M | -48.7% |
| FY2024 | -$185.1M | -85.5% |
| FY2023 | -$99.7M | -53.5% |
| FY2022 | -$65.0M | -62.4% |
| FY2021 | -$40.0M | -167.6% |
| FY2020 | -$14.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026